BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Ischemia
,
Embryo
,
Neocentromeres
,
Fenofibrate
,
rs2300478
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
myelodysplastic syndromes
Summary
General Info
Curated Studies
Most Correlated Studies
Monocyte gene expression in chromosome 5q deletion syndrome - before and after treatment
Bone marrow mononuclear cells of refractory anemia with ring sideroblasts and SF3B1 mutation
Myeloid malignancies with chromosome 5q deletions: differences in miR-146a expression
Hematopoietic progenitor cells with TP53 R209fs mutation and chromosome 5q deletion
OMIM - Cancer
Explore Curated Studies Results
Literature
Most Relevant Literature
An overview of myelodysplastic syndromes.
Myelodysplastic syndromes, thy name is heterogeneity.
Germline Predisposition to Myelodysplastic Syndromes.
Updates in Risk Stratification in Myelodysplastic Syndromes.
Considerations for Drug Development in Myelodysplastic Syndromes.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes
Belinostat in Treating Patients With Myelodysplastic Syndromes
CPX-351 in Higher Risk Myelodysplastic Syndromes
Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients
BMS-986253 in Myelodysplastic Syndromes
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ